420 related articles for article (PubMed ID: 18650647)
1. Lateral pelvic lymph node dissection or chemoradiotherapy: which is the procedure of choice to reduce local recurrence rate in lower rectal cancer?
Watanabe T; Matsuda K; Nozawa K; Kobunai T
Ann Surg; 2008 Aug; 248(2):342-3; author reply 343. PubMed ID: 18650647
[No Abstract] [Full Text] [Related]
2. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection.
Kim TH; Jeong SY; Choi DH; Kim DY; Jung KH; Moon SH; Chang HJ; Lim SB; Choi HS; Park JG
Ann Surg Oncol; 2008 Mar; 15(3):729-37. PubMed ID: 18057989
[TBL] [Abstract][Full Text] [Related]
3. [Current debates on rectal cancer].
Lasser P
Gastroenterol Clin Biol; 2002 May; 26(5 Suppl):B78-85. PubMed ID: 12068274
[No Abstract] [Full Text] [Related]
4. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
[TBL] [Abstract][Full Text] [Related]
5. Lateral pelvic lymph node dissection using latero-vesical approach with aspiration procedure for advanced lower rectal cancer.
Kawahara H; Watanabe K; Ushigome T; Yanagisawa S; Kobayashi S; Yanaga K
Hepatogastroenterology; 2012; 59(113):116-9. PubMed ID: 21940358
[TBL] [Abstract][Full Text] [Related]
6. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
Hughes R; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Livingstone JI; McDonald PJ; Meyrick Thomas J; Mitchell IC; Northover JM; Phillips R; Wallace M; Windsor A; Novell JR
Int J Colorectal Dis; 2006 Jan; 21(1):11-7. PubMed ID: 15864605
[TBL] [Abstract][Full Text] [Related]
7. [Radiotherapy of rectal carcinoma].
Curschmann J; Greiner RH
Ther Umsch; 1998 Jul; 55(7):439-41. PubMed ID: 9702114
[TBL] [Abstract][Full Text] [Related]
8. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
9. Hydronephrosis as a prognostic factor in pelvic recurrence from rectal and colon carcinomas.
Larsen SG; Wiig JN; Giercksky KE
Am J Surg; 2005 Jul; 190(1):55-60. PubMed ID: 15972173
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of lymph node ratio after neoadjuvant chemoradiation and rectal cancer surgery.
Klos CL; Bordeianou LG; Sylla P; Chang Y; Berger DL
Dis Colon Rectum; 2011 Feb; 54(2):171-5. PubMed ID: 21228664
[TBL] [Abstract][Full Text] [Related]
12. Lymphadenectomy in the surgical management of penile cancer.
Protzel C; Alcaraz A; Horenblas S; Pizzocaro G; Zlotta A; Hakenberg OW
Eur Urol; 2009 May; 55(5):1075-88. PubMed ID: 19264390
[TBL] [Abstract][Full Text] [Related]
13. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic salvage lateral pelvic lymph node dissection for locally recurrent rectal cancer.
Akiyoshi T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
Colorectal Dis; 2015 Oct; 17(10):O213-6. PubMed ID: 26277783
[TBL] [Abstract][Full Text] [Related]
15. Surgery and intraoperative electron radiotherapy in recurrent or metastatic oligotopic extrapelvic cancer: long-term outcome.
Calvo FA; González ME; González-San Segundo C; González-Bayón L; Lozano MA; Santos-Miranda JA; Alvarez E; García-Sabrido JL
Eur J Surg Oncol; 2012 Oct; 38(10):955-61. PubMed ID: 22819147
[TBL] [Abstract][Full Text] [Related]
16. The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer.
Berho M; Oviedo M; Stone E; Chen C; Nogueras J; Weiss E; Sands D; Wexner S
Colorectal Dis; 2009 Mar; 11(3):254-8. PubMed ID: 18513188
[TBL] [Abstract][Full Text] [Related]
17. Role of lymphadenectomy for prostate cancer: indications and controversies.
La Rochelle JC; Amling CL
Urol Clin North Am; 2011 Nov; 38(4):387-95, v. PubMed ID: 22045170
[TBL] [Abstract][Full Text] [Related]
18. Treatment strategy for locally recurrent rectal cancer.
Moriya Y
Jpn J Clin Oncol; 2006 Mar; 36(3):127-31. PubMed ID: 16598032
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
[TBL] [Abstract][Full Text] [Related]
20. The role of lymphadenectomy for testicular cancer: indications, controversies, and complications.
Tarin T; Carver B; Sheinfeld J
Urol Clin North Am; 2011 Nov; 38(4):439-49, vi. PubMed ID: 22045175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
